BETHLEHEM, Pa., March 28, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President & CEO, will speak to the investment community at the 10 th Annual Needham Healthcare Conference in New York City. The conference will be simultaneously webcast over the Internet.

Mr. Michels is scheduled to speak April 5, 2011, at approximately 9:20 am Eastern Time (6:20 am Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Info link.  A replay of the webcast will be available on OraSure Technologies' web site for seven days.  Alternatively, you can access the live webcast of the presentation via the following link http://www.wsw.com/webcast/needham44/osur/.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. For more information on the Company, please go to www.orasure.com .

The OraSure Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6440
CONTACT: Company contact:                  Ronald H. Spair         Chief Financial Officer         610-882-1820         Investorinfo@orasure.com         www.orasure.com

company logo

If you liked this article you might like

Stocks Under $10 Portfolio: Not Resting on Our Laurels

How to Cash in on the Fight Against the Zika Virus

OraSure (OSUR) Stock Spikes, Upgraded at Stephens

4 Stocks for Fighting Zika

OraSure Technologies (OSUR) Stock Jumps on Zika Test Contract